Related Experiment Video
Updated: Jul 15, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Identification and Validation of a Prognostic Signature Based on mRNAs Associated with Low-Density Lipoprotein
Lei Xie1, Yajie Zhou1, Zijian Hu1
1Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Background:
Low-density lipoprotein receptor-related protein (LRP) is integral to protein synthesis and contributes significantly to tumor initiation and growth. However, the role of LRP-related mRNAs (LRPMRs) in KIRC progression remains unclear. Our study investigates the potential use of LRPMRs as prognostic markers in patients with KIRC.
Methods:
Clinical and transcriptomic data of KIRC patients were obtained from The Cancer Genome Atlas (TCGA) database for model construction and performance evaluation. A nomogram integrating clinical characteristics and the risk model was then established. To explore the clinical significance and underlying mechanisms, we analyzed the tumor microenvironment (TME), evaluated tumor mutational burden (TMB), performed gene set enrichment analysis, and predicted drug sensitivity. The mRNA expression was assessed using RT-qPCR.
Results:
A six-LRPMR-based model was developed and provided significant prognostic information. Kaplan-Meier analysis demonstrated worse survival outcomes for high-risk (H-R) patients (p < 0.001). A nomogram incorporating the risk model showed improved predictive accuracy compared with the clinical model alone (AUC = 0.761). GSEA highlighted proximal tubule transport and propanoate metabolism pathways as significantly enriched in the low-risk (L-R) group, while the H-R group displayed enrichment in CD22-mediated BCR regulation and FCGR activation pathways. Higher TMB in the H-R cohort predicted a poor prognosis. TME analysis suggested that H-R patients may respond less favorably to immunotherapy. Drug sensitivity analysis indicated that H-R patients were more sensitive to Staurosporine and Sabutoclax, whereas L-R patients were more sensitive to dihydrorotenone and osimertinib. RT-qPCR validated differential mRNA expression between KIRC and normal cells.
Conclusion:
This six-LRPMR-based prognostic model provides valuable insights for prognosis assessment and personalized treatment selection in KIRC.
More Related Videos
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
MicroRNAs

